Basic Information
RNALocate ID: RLID:11001933
RNA Symbol: hsa-miR-154-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-154-5p
RNA ID: miRBase:MIMAT0000452
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001838 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11001932 Exosome Brain tissue 23382797
RLID-D:11000380 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001180 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-154-5p Oral squamous cell carcinoma MNDR-E-MI-17418
MNDR hsa-miR-154-5p Medulloblastoma MNDR-E-MI-17419
MNDR hsa-miR-154-5p High-grade serous ovarian carcinoma MNDR-E-MI-17420
MNDR hsa-miR-154-5p Ovarian clear cell carcinoma MNDR-E-MI-17421
MNDR hsa-miR-154-5p Uterine corpus endometrial carcinoma MNDR-E-MI-17422
MNDR hsa-miR-154-5p Estrogen-receptor positive breast cancer MNDR-E-MI-17423
MNDR hsa-miR-154-5p Estrogen-receptor negative breast cancer MNDR-E-MI-17424
MNDR hsa-miR-154-5p Progesterone-receptor positive breast cancer MNDR-E-MI-17425
MNDR hsa-miR-154-5p Progesterone-receptor negative breast cancer MNDR-E-MI-17426
MNDR hsa-miR-154-5p Her2-receptor positive breast cancer MNDR-E-MI-17427
MNDR hsa-miR-154-5p Breast cancer luminal MNDR-E-MI-17428
MNDR hsa-miR-154-5p Dermatomyositis MNDR-E-MI-17429
MNDR hsa-miR-154-5p Prostate cancer MNDR-E-MI-17430
MNDR hsa-miR-154-5p Gastric cancer MNDR-E-MI-17431
MNDR hsa-miR-154-5p Alzheimer disease MNDR-E-MI-17432
MNDR hsa-miR-154-5p Bladder cancer MNDR-E-MI-17433
MNDR hsa-miR-154-5p Dysautonomia familial MNDR-E-MI-17434
MNDR hsa-miR-154-5p Muscular dystrophy duchenne MNDR-E-MI-17435
MNDR hsa-miR-154-5p Facioscapulohumeral muscular dystrophy MNDR-E-MI-17436
MNDR hsa-miR-154-5p Head and neck cancer MNDR-E-MI-17437
MNDR hsa-miR-154-5p Huntington disease MNDR-E-MI-17438
MNDR hsa-miR-154-5p Lung cancer MNDR-E-MI-17439
MNDR hsa-miR-154-5p Endometrial cancer MNDR-E-MI-17440
MNDR hsa-miR-154-5p Parkinson disease MNDR-E-MI-17441
MNDR hsa-miR-154-5p Breast cancer MNDR-E-MI-17442
MNDR hsa-miR-154-5p Thyroid cancer MNDR-E-MI-17443
MNDR hsa-miR-154-5p Pituitary neoplasms MNDR-E-MI-17444
MNDR hsa-miR-154-5p Pancreatic cancer MNDR-E-MI-17445
MNDR hsa-miR-154-5p Melanoma MNDR-E-MI-17446
MNDR hsa-miR-154-5p Nephroblastoma MNDR-E-MI-17447
MNDR hsa-miR-154-5p Colon cancer MNDR-E-MI-17448
MNDR hsa-miR-154-5p Familial ovarian cancer MNDR-E-MI-17449
MNDR hsa-miR-154-5p Prostate adenocarcinoma MNDR-E-MI-17450
MNDR hsa-miR-154-5p Carcinoma ductal breast MNDR-E-MI-17451
MNDR hsa-miR-154-5p Balkan nephropathy MNDR-E-MI-17452
MNDR hsa-miR-154-5p Glioblastoma MNDR-E-MI-17453
MNDR hsa-miR-154-5p Astrocytoma MNDR-E-MI-17454
MNDR hsa-miR-154-5p Glioma MNDR-E-MI-17455
MNDR hsa-miR-154-5p Nemaline myopathy MNDR-E-MI-17456
MNDR hsa-miR-154-5p Amyotrophic lateral sclerosis MNDR-E-MI-17457
MNDR hsa-miR-154-5p Pancreatic ductal adenocarcinoma MNDR-E-MI-17458
MNDR hsa-miR-154-5p Meningioma MNDR-E-MI-17459
MNDR hsa-miR-154-5p Uterine cancer MNDR-E-MI-17460
MNDR hsa-miR-154-5p Gastric adenocarcinoma MNDR-E-MI-17461
MNDR hsa-miR-154-5p Cervical squamous cell carcinoma MNDR-E-MI-17462
MNDR hsa-miR-154-5p Bone-invasive pituitary adenoma MNDR-E-MI-17463
MNDR hsa-miR-154-5p Lung adenocarcinoma MNDR-E-MI-17464
MNDR hsa-miR-154-5p Adrenocortical carcinoma MNDR-E-MI-17465
MNDR hsa-miR-154-5p Thyroid carcinoma MNDR-E-MI-17466
MNDR hsa-miR-154-5p Ovarian carcinoma MNDR-E-MI-17467
MNDR hsa-miR-154-5p Bladder urothelial carcinoma MNDR-E-MI-17468
MNDR hsa-miR-154-5p Pancreatic adenocarcinoma MNDR-E-MI-17469
MNDR hsa-miR-154-5p Carcinoma renal cell MNDR-E-MI-17470
MNDR hsa-miR-154-5p Kidney renal papillary cell carcinoma MNDR-E-MI-17471
MNDR hsa-miR-154-5p Renal clear cell carcinoma MNDR-E-MI-17472
MNDR hsa-miR-154-5p Cholangiocarcinoma MNDR-E-MI-17473
MNDR hsa-miR-154-5p Esophageal cancer MNDR-E-MI-17474
MNDR hsa-miR-154-5p Synovial sarcoma MNDR-E-MI-17475
MNDR hsa-miR-154-5p Head and neck squamous cell carcinoma MNDR-E-MI-17476
MNDR hsa-miR-154-5p T acute lymphoblastic leukemia MNDR-E-MI-17477
MNDR hsa-miR-154-5p Acute t cell leukemia MNDR-E-MI-17478
MNDR hsa-miR-154-5p Breast invasive carcinoma MNDR-E-MI-17479
MNDR hsa-miR-154-5p Hepatocellular carcinoma MNDR-E-MI-17480
MNDR hsa-miR-154-5p Familiar ovarian carcinoma MNDR-E-MI-17481
MNDR hsa-miR-154-5p Neuroblastoma MNDR-E-MI-17482
MNDR hsa-miR-154-5p Colorectal cancer MNDR-E-MI-17483
MNDR hsa-miR-154-5p Nasopharynx carcinoma MNDR-E-MI-17484
MNDR hsa-miR-154-5p Nasopharyngeal cancer MNDR-E-MI-17485
MNDR hsa-miR-154-5p Prostatic neoplasms MNDR-E-MI-17486
MNDR hsa-miR-154-5p Polymyositis MNDR-E-MI-17487
MNDR hsa-miR-154-5p Non-alcoholic fatty liver disease MNDR-E-MI-17488
MNDR hsa-miR-154-5p Breast cancer her3+ negative MNDR-E-MI-17489
MNDR hsa-miR-154-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-17490
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CCND2 Homo sapiens RR00295032
TOP